Skip to main content
. 2011 Jul;4(4):237–248. doi: 10.1177/1756285611405395

Table 2.

Psychiatric and neurologic symptoms in NMDA, AMPA and GABA (b) surface antibodies.

Antibody Psychiatric manifestation Neurologic findings MRI Treatment
NMDA Psychosis, anxiety, bizarreness, delusions, paranoid behaviour ‘catatonic state’ Reduced level of consciousness seizure hypoventilation autonomic disturbances dyskinesias Movement disorders Rare Treatment either of tumour or immunotherapy
AMPA Memory loss confusion, aggression Common but not necessarily Tumour treatment or immunotherapy. Relapse possible
GABA (b) Psychosis, hallucinations, confusion Seizures Common (small number of cases) Improvement due to tumour treatment, or immunotherapy.